Correlation Between PDS Biotechnology and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Seres Therapeutics, you can compare the effects of market volatilities on PDS Biotechnology and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Seres Therapeutics.
Diversification Opportunities for PDS Biotechnology and Seres Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between PDS and Seres is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Seres Therapeutics go up and down completely randomly.
Pair Corralation between PDS Biotechnology and Seres Therapeutics
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to under-perform the Seres Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, PDS Biotechnology Corp is 1.68 times less risky than Seres Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Seres Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 93.00 in Seres Therapeutics on August 24, 2024 and sell it today you would lose (19.82) from holding Seres Therapeutics or give up 21.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. Seres Therapeutics
Performance |
| Timeline |
| PDS Biotechnology Corp |
| Seres Therapeutics |
PDS Biotechnology and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and Seres Therapeutics
The main advantage of trading using opposite PDS Biotechnology and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
| Seres Therapeutics vs. ZyVersa Therapeutics | Seres Therapeutics vs. Sonnet Biotherapeutics Holdings | Seres Therapeutics vs. Zura Bio Limited | Seres Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |